Logo
Annual
Results
for the year ended
30 June
2022
RE-IMAGINING
THE HEALTHCARE
SYSTEM

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

EXCEL DOWNLOAD
  
change 
Year ended 
30 June 
2022 
R'000
 
Year ended 
30 June 
2021 
R'000 
Revenue from contracts with customers  8,0  8 722 570  8 074 418 
Dividends received     —  1 000 
Fair value gains/(losses)    6 369  (6 307)
Finance income     15 086  19 595 
Other income     563  3 061 
Total income  8,1  8 744 588  8 091 767 
Cost of distribution of pharmaceutical products     (98 694) (95 991)
Cost of pharmaceutical products and finished goods     (2 022 726) (1 809 606)
Employee benefit costs     (2 364 724) (2 278 354)
Other expenses     (2 879 641) (2 628 627)
Amortisation     (231 269) (195 027)
Rent and property costs     (96 089) (90 914)
Right of use assets depreciation     (63 287) (66 564)
Depreciation     (87 299) (78 202)
IT costs     (152 416) (62 994)
Write off of intangibles     (635) (26 793)
Impairment of intangibles     —  (42 349)
Reversal of impairment of intangibles     —  39 167 
Impairment of loans     (3 203) (7 196)
Share of profits from associates and joint ventures     6 991  8 294 
Interest on lease liabilities     (19 354) (21 420)
Finance costs     (57 049) (35 673)
Profit before tax  (3.5) 675 193  699 518 
Income tax expense – continuing operations  (6.0) (193 453) (205 741)
Profit from continuing operations  (2.4) 481 740  493 777 
Loss from discontinued operations (NOTE 3)    —  (14 008)
Loss on disposal of subsidiaries (NOTE 3)    —  (10 014)
Profit for the year  2.6  481 740  469 755 
Profit for the year attributable to:          
Owners of Parent     314 276  302 033 
Non-controlling interest     167 464  167 722 
      481 740  469 755 
Profit for the year attributable to equity shareholders arises from:          
Continuing operations     314 276  316 041 
Discontinued operations     —  (14 008)
      314 276  302 033 
Profit for the year     481 740  469 755 
Other comprehensive income          
Components of other comprehensive income that will not be reclassified to profit or loss          
Remeasurement of post-employment benefit obligations     (24) 179 
Income tax relating to these items     (50)
Total other comprehensive income that will not be reclassified to profit or loss      (18)  129 
Components of other comprehensive income that will be reclassified to profit or loss          
Exchange differences on translation of foreign operations          
Foreign exchange benefit/(loss) of continuing operations     1 519  (5 636)
Foreign exchange benefit of discontinued operations     —  11 658 
Total other comprehensive income that will be reclassified to profit or loss      1 519   6 022 
Total other comprehensive income net of tax     1 501  6 151 
Total comprehensive income  1.5  483 241  475 906 
Comprehensive income attributable to:          
Comprehensive income, attributable to owners of parent     315 341  310 655 
Comprehensive income, attributable to non-controlling interests     167 900  165 251 
      483 241  475 906 
* The above Consolidated Statement of Comprehensive Income is reflected in a similar format to the Annual Financial Statements. For a comparative view to operating performance in line with previous years, refer to the supplementary information.